Latest / The BioHub - by Avetix
Episode 178 - Kevin Finney - Chairman, President and CEO at Autobahn Therapeutics
In this episode, Ben sits down with Kevin Finney, President and CEO of Autobahn Therapeutics, for a conversation on biotech leadership, CNS drug development, and what it takes to build companies around difficult but high-impact areas of medicine.
Kevin brings deep experience across company formation, financing, business development, and exits, including leadership roles at Abide Therapeutics, which was acquired by Lundbeck, and Zavante Therapeutics, which was later acquired by Nabriva.
We discussed his career journey, the lessons learned from building and selling biotech companies, and why…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.